Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Share Capital	Additional Paid-in Capital	Capital Redemption Reserve	Accumulated Other Comprehensive (Income) Loss	Accumulated Deficit
Balance at beginning of the year at Dec. 31, 2023	$ (229)	$ 1,324	$ 174,754	$ 52,194	$ (1,040)	$ (227,461)
Balance at the beginning of the year (in shares) at Dec. 31, 2023		13,234,315,298
Issuance of share capital related to financing, net of issuance costs	1,664	$ 264	1,400
Issuance of share capital related to financing, net of issuance costs (in shares)		2,641,228,000
Vesting of restricted shares	3	$ 10	(7)
Vesting of restricted shares (in shares)		97,578,000
Stock-based compensation	296		296
Foreign currency translation	279				279
Net loss	(5,566)					(5,566)
Balance at the end of the year at Mar. 31, 2024	(3,553)	$ 1,598	176,443	52,194	(761)	(233,027)
Balance at the end of the year (in shares) at Mar. 31, 2024		15,973,121,298
Balance at beginning of the year at Dec. 31, 2024	22,229	$ 5,319	212,706	52,194	(738)	(247,252)
Balance at the beginning of the year (in shares) at Dec. 31, 2024		53,186,919,523
Issuance of share capital related to financing, net of issuance costs	2,242	$ 457	1,785
Issuance of share capital related to financing, net of issuance costs (in shares)		4,566,062,000
Stock-based compensation	1,015		1,015
Foreign currency translation	(35)				(35)
Net loss	(3,705)					(3,705)
Balance at the end of the year at Mar. 31, 2025	$ 21,746	$ 5,776	$ 215,506	$ 52,194	$ (773)	$ (250,957)
Balance at the end of the year (in shares) at Mar. 31, 2025		57,752,981,523